LAN Xuerong, HUANG Xuemin, LIU Zhifang, ZENG Guangfan. Cost and effectiveness analysis on different schemes in the treatment of mycoplasma pneumonia complicated with bacterial infection[J]. Journal of Pharmaceutical Practice and Service, 2017, 35(4): 375-378. doi: 10.3969/j.issn.1006-0111.2017.04.022
Citation:
|
LAN Xuerong, HUANG Xuemin, LIU Zhifang, ZENG Guangfan. Cost and effectiveness analysis on different schemes in the treatment of mycoplasma pneumonia complicated with bacterial infection[J]. Journal of Pharmaceutical Practice and Service, 2017, 35(4): 375-378. doi: 10.3969/j.issn.1006-0111.2017.04.022
|
Cost and effectiveness analysis on different schemes in the treatment of mycoplasma pneumonia complicated with bacterial infection
- Received Date: 2016-11-21
- Rev Recd Date:
2017-03-20
-
Abstract
Objective To evaluate the cost and effectiveness for five combination therapy of β-lactam antibiotic with azithromycin in the treatment of mycoplasma pneumonia (MP) complicated with bacterial infection. Methods A retrospective study was conducted to compare the cost and effectiveness of the five regimens. Results The effective rates of group A, B, C, D and E were 97.29%, 100%, 96.55%, 95.65% and 97.36% respectively. The costs were (2 831.13±910.16) yuan,(2 816.31±127.11) yuan,(3 453.29±645.89) yuan,(4 382.42±1484.26) yuan,(3 703.39±124.86) yuan respectively. The cost-effectiveness ratios were (29.10±9.36), (28.16±5.24), (35.77±6.69), (38.04±7.90)and (35.26±10.10)respectively. Conclusion In terms of pharmacoeconomics, the combination of cefpiramide with azithromycin in group B has the lowest cost and cost-effectiveness ratio. This regimen is the most effective and economically favored combination. It is the treatment of first choice for pediatric MP patients complicated with bacterial infection.
-
References
[1]
|
王晓红, 王岱明. 注射用阿奇霉素治疗儿童肺炎的临床疗效及安全性[J].中国新药杂志, 2001, 10(9): 695-696. |
[2]
|
柯莉芹, 王凤美, 李银洁, 等. 儿童肺炎支原体肺炎流行病学特征[J].中国当代儿科杂志, 2013, 15(1): 33-36. |
[3]
|
谢振伟,臧彦楠,王晓玲, 等. 四种方案治疗支原体肺炎合并细菌感染的药物经济学评价[J].中国医院药学杂志, 2015,35(23): 2139-2142. |
[4]
|
陆 权, 李昌崇.再论儿童社区获得性肺炎[J]. 中华儿科杂志,2013,51(10): 721-723. |
[5]
|
张 琳.支原体肺炎发病机制及临床分析[J].第一军医大学学报, 2005, 25(12):1574-1576. |
[6]
|
中华医学会儿科学分会呼吸学组,《中华实用儿科临床杂志》编辑委员会. 儿童肺炎支原体肺炎诊治专家共识 (2015 年版)[J]. 中华实用儿科临床杂志, 2015, 30(17): 1304-1308. |
[7]
|
李 红.红霉素联合阿奇霉素治疗小儿支原体肺炎疗效观察[J]. 临床合理用药杂志,2013,6(26): 75-76. |
[8]
|
吴玉洲, 韦 冠, 陈永法. 儿科领域的药物经济学研究现状初探——基于美国《药物经济学》杂志[J].中国药物经济学, 2013, 8(2): 12-15. |
[9]
|
胡春阳,韩 晟,陈路佳,等.他氟前列素与拉坦前列素治疗原发性开角型青光眼的成本效果分析[J].中国新药杂志,2013,22(23): 2831-2836. |
-
-
Proportional views
-